Amblyopia Therapeutic Apparatus is a device used for the treatment of Amblyopia, also called “lazy eye”. Amblyopia is decreased vision in one or both eyes due to abnormal development of vision in infancy or childhood. In amblyopia, there may not be an obvious problem of the eye. Vision loss occurs because nerve pathways between the brain and the eye aren't properly stimulated. The brain “learns” to see only blurry images with the amblyopic eye even when glasses are used. As a result, the brain favors one eye, usually due to poor vision in the other eye.

Scope of the Report:
The global average sales price of Amblyopia Therapeutic Apparatus is in the decreasing trend, from 518 USD/Unit in 2012 to 473 USD/Unit in 2016. With the situation of global economy, sales prices will be in decreasing trend in the following five years.

Amblyopia Therapeutic Apparatus is widely used in Homecare, hospital and Ophthalmologic Center. The most proportion of Amblyopia Therapeutic Apparatus is hospital, and the sales in 2016 are about 98 K Unit. The trend of hospital application is decreasing.

China is the largest consumption market of Amblyopia Therapeutic Apparatus, as doctors in Europe and USA prefer the practice treatment, patching, pharmacologic blurring, etc. China account for 92% market share in 2016, and the other account for 8%.

Market competition is intense. Guangzhou Boshi, Guangzhou Shijia, Xi'an Huaya, Shenzhen ElmmediCare and Guangzhou Shizheng are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

The worldwide market for Amblyopia Therapeutic Apparatus is expected to grow at a CAGR of roughly 2.3% over the next five years, will reach 64 million US$ in 2024, from 56 million US$ in 2019, according to a new study.
This report focuses on the Amblyopia Therapeutic Apparatus in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Guangzhou Boshi
Guangzhou Shijia
Xi'an Huaya
Shenzhen ElmmediCare
Guangzhou Shizheng
Xi'an Aile
Zhongke Hengtong
Beijing Tongming

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Color/Icon Apparatus
Comprehensive Apparatus

Market Segment by Applications, can be divided into
Homecare
Hospital
Ophthalmologic Center

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Amblyopia Therapeutic Apparatus product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Amblyopia Therapeutic Apparatus, with price, sales, revenue and global market share of Amblyopia Therapeutic Apparatus in 2017 and 2018.
Chapter 3, the Amblyopia Therapeutic Apparatus competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Amblyopia Therapeutic Apparatus breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Amblyopia Therapeutic Apparatus market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Amblyopia Therapeutic Apparatus sales channel, distributors, customers, research findings and conclusion, appendix and data source.